At the IGTP TODAY

News

Respira, the new ventilator device developed gets the go ahead from the AEMPS for clinical trials

The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved a clinical trial with the ventilation device RESPIRA developed by GAPInnova with the support of professionals from the Hospital Clínic Barcelona, the Germans Trias I Pujol Research Institute and the University of Barcelona. This is the second device developed with the support of these organizations to be approved by the AEMPS for testing on patients at the Hospital Clinic Barcelona and at Can Ruti. The prototype of the RESPIRA device mechanizes manual ressusitations with AMBU devices providing automatic respiration assistance and monitoring.

The IGTP is working to respond to COVID-19

The Germans Trias I Pujol Research Institute (IGTP) is working alongside the hospital and at the service of the Ministry of Health of the Government of Catalonia to make all the necessary disposable material and resources available for the diagnosis and treatment of COVID-19. The research groups at the centre are also working against the clock to prepare projects for the extraordinary competitive funding calls that have been issued to fund research into SARS-CoV-2 and the disease COVID-19.

The IGTP and the Èpica Foundation of the Fura dels Baus present the results of the workshop ‘Complex Systems’

Last week the preliminary results of a collaboration between the scenic arts and science, or in other words, between the Èpica Foundation of the Fura dels Baus and the IGTP were presented. The workshop and the resulting performance took place last November and now the researchers are processing the data collected from the experience, which will be useful for their respective research projects.

- Campus Can Ruti, Research

New European initiative, RECOGNISED, will determine the usefulness of the retina as a tool for identifying people with type 2 diabetes and cognitive impairment

The IGTP is participating in this recently launched EU-funded project to explore the biological pathways that may link the alterations observed in the retina with those present in the brain in people with type 2 diabetes (T2D). In this way, the RECOGNISED project hopes to use the eye as if it was a window into the brain.

- Campus Can Ruti, Research

A team at Germans Trias treat a patient with a new bio-implant to repair heart tissue after a heart attack

The pioneering surgery that took place last May at the Germans Trias Hospital. The bio-implant, based on umbilical cord stem cells, has been developed by the Cardiovascular Disease Research Group (ICREC) at Germans Trias, led by Antoni Bayés-Genís in a research line, which they have been pursuing for 10 years. The new therapy has been developed with the collaboration of the Blood and Tissue Bank (BST) and the Institute of Bioengineering of Catalonia (IBEC); this is the first step of the application in clinical practice and the group will continue to monitor safety and the capacity of cardiac tissue to recover

Germans Trias Professionals organize the first National Meeting on Neurofibromatosis Type 2

Last Friday the first update meeting at national level to take a global view of the healthcare situation and present the latest research data for Neurofibromatosis type 2 (NF2) took place at the IGTP. This pioneering event was organized by the members of the National Reference Centre in genetic neuro-cutaneous syndromes (Facomatosis), (CSUR) on the Can Ruti Campus and also included patients and families affected by the disease.

The IGTP promotes science for high-school students at the celebration of the 24th Science Week at Can Ruti

This week the IGTP and other centres hosted the “Can Ruti Open Door Session” within Science Week in Badalona; the Science Week is a national event organized by the Spanish Foundation for Science and Technology (FECYT). This year nearly 200 high school students from various educational centres have visited the research facilities at nine different organizations on the Can Ruti Campus and learned about studies taking place there.

Researchers from the IGTP take part in a series of popular science talks on rare diseases

On Friday 8 November the first of the series of popular science talks organized by the Friends of Can Ruti (Amics de Can Ruti) took place in the Joan Coromines Library in Masnou and the Sant Andreu Library in Llavaneres. This is the second series of informative talks and once again they are inspired by the topic of this year's TV3 Marathon, which is rare diseases. Professionals from the IGTP and the Germans Trias Hospital are taking part.

The Comparative Medicine and Bioimaging Centre (CMCiB) opens its new facilities for research with bioimage

The Director of the Germans Trias i Pujol Research Institute (IGTP), Manel Puig, and the President of the Canon Medical Systems Corporation (Canon Medical), Toshio Takiguchi, visited the CMCiB on Monday 14 October to view the new bioimaging facilities that complete the center as a pioneering research platform in comparative medicine. The CMCiB, a center promoted by the IGTP and a benchmark in comparative medicine, bioimaging and computational models, is a pioneer in the application of alternative methods of biomedical research that directly affect the improvement of people's health.